African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.

Source:http://linkedlifedata.com/resource/pubmed/id/19564528

J. Clin. Oncol. 2009 Aug 1 27 22 e35-7; author reply e38-9

Download in:

View as

General Info

PMID
19564528